政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/38445
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  全文笔数/总笔数 : 113311/144292 (79%)
造访人次 : 50931515      在线人数 : 988
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    请使用永久网址来引用或连结此文件: https://nccur.lib.nccu.edu.tw/handle/140.119/38445


    题名: 生技製藥產業併購策略─羅氏集團與基因科技公司個案研究
    Strategic merger & acquisition in bio-pharmaceutical industry-Roche and genentech case study
    作者: 陳潔萱
    Chen, Sarah
    贡献者: 何小台
    Ho, Chester
    陳潔萱
    Chen, Sarah
    关键词: 生技製藥
    日期: 2009
    上传时间: 2010-06-15 16:24:56 (UTC+8)
    摘要: 生技製藥產業併購策略
    The biotechnology companies started with the development of genetic engineering and antibody production in the U.S. and until today U.S. is still the leader in this industry. In recent years, they are becoming particular interest to established pharmaceutical companies. This thesis will first introduce the characteristic of pharmaceutical industry and its current situations, Next to explain pharmaceutical company’s unique relationship with biotechnology by studying the merger and acquisition case of Roche and Genentech. With the results, we will have better understanding of the business challenge and strategy for the industry.
    International MBA Program i
    College of Commerce i
    National Chengchi University i
    A Thesis i
    1. Introduction 1
    1.1. Research Background and Motive 1
    1.2. Research Objective 2
    2. Motivation for Merger and Acquisition 3
    2.1. Value Creation Theory 3
    2.2. The Synergy Creation Theory 3
    2.3. The Disciplinary Takeover Theory 4
    3. Company Background 5
    3.1. The Roche Group 5
    3.1.1. History and Background 5
    3.1.2. Company Structure 6
    3.1.3. Financial Result 8
    3.1.4. Product and Services 9
    3.1.5. Corporate Strategy 10
    3.2. The Genentech Group 11
    3.2.1. History and Background 11
    3.2.2. Company Structure 11
    3.2.3. Financial Result 12
    3.2.4. Product and Services 13
    3.2.5. Corporate Strategy 14
    4. Industry Analysis 16
    4.1. Industry Overview 16
    4.2. Industry Risk 17
    4.2.1. Research & Development Risk 18
    4.2.2. Risk of Substitute Products 22
    4.2.3. Regulation Risk 25
    4.2.4. Product Promotion Risk 26
    4.3. Industry Trend 27
    4.3.1. Cost Saving 27
    4.3.2. More Mergers and Acquisition to Come 28
    4.3.3. Personalized HealthCare 31
    5. Merger Transaction Case Analysis 32
    5.1. Brief History of the First Acquisition in 1990 32
    5.2. Roche Offer to Acquire all Outstanding Shares of Genentech 34
    5.3. The Challenge Ahead 37
    5.3.1. Keeping the Genentech Culture 37
    5.3.2. The New Structure 38
    5.3.3. Why Now 39
    5.3.4. Financial Value Drivers 40
    6. Summary and Conclusion 42
    參考文獻: 1. Decker, Susan. "Pfizer Wins New Lipitor Patent Expiring in June 2011 (Update2) ". Bloomberg.com. January 6, 2010 <http://www.bloomberg.com>
    2. Gassmann, Oliver, Gerrit Reepmeyer, and Maximilian von Zedtwitz. Leading Pharmaceutical Innovation. Berlin Heidelberg: Springer-Verlag, 2008.
    3. Grabowski, H.; Vernon, J.; DiMasi, J. “Returns on Research and Development for 1990s New Drug Introductions.” Pharmacoeconomics 20, Dec. 2002: 11-29.
    4. Saftlas, Herman. "Industry Surveys Healthcare: Pharmaceuticals". Standard & Poor`s November 27, 2008: 1-38.
    5. Roche Financial Report 2008. Basel, Switzerland: F. Hoffmann-La Roche Ltd., 2009.
    6. We are Genentech 2008 Annual Report. South San Francisco, CA: Genentech Inc., 2009.
    7. "Company Portrait". Roche Global Web Site. December 24, 2009 <http://www.roche.com/about_roche/at_a_glance/company_portrait.htm>.
    8. "Company Structure". Roche Global Web Site. December 24, 2009 <http://www.roche.com/about_roche/at_a_glance/company_structure.htm>.
    9. "Pharmaceutical R&D". Roche Global Web Site. December 24, 2009 <http://www.roche.com/research_and_development/r_d_overview/pharmaceuticals.htm>.
    10. "Corporate Overview Home". Genentech official website. December 24, 2009 <http://www.gene.com/gene/about/corporate/>.
    11. "Research Focus Areas". Genentech official website. December 24, 2009 <http://www.gene.com/gene/research/focusareas/>.
    12. Huckman, Mike. "Roche-Genentech: As The Deal Turns ". CNBC. January 9, 2010 <http://www.cnbc.com>.
    13. Morrill, David. "Roche, Genentech now one". ContraCostaTimes. January 6, 2009 <http://www.contracostatimes.com/business>
    14. “Pharmaceutical Research and Manufacturers of America (PhRMA)”, 2007 R&D Report: The pursuit of High Performance through Research and Development, Dec. 26 2009, http://www.phrma.org
    15. Pollack, Andrew. "Genentech-Roche Deal May Spur Similar Ties". The New York Times. January 6, 2010 <http://www.nytimes.com/pages/business/index.html>.
    16. "Roche Initiates Hostile Takeover Bid for Genentech at US$86.5 per Share". Global Insight. January 9, 2010 <http://www.ihsglobalinsight.com/>
    17. Schmit, Julie. "Genentech shares surge on Roche`s $44 billion offer". USA Today. January 6, 2010 <http://www.usatoday.com/money/industries/health>.
    描述: 碩士
    國立政治大學
    國際經營管理碩士班(IMBA)
    95933007
    98
    資料來源: http://thesis.lib.nccu.edu.tw/record/#G0959330071
    数据类型: thesis
    显示于类别:[國際經營管理英語碩士學程IMBA] 學位論文

    文件中的档案:

    档案 大小格式浏览次数
    index.html0KbHTML2537检视/开启


    在政大典藏中所有的数据项都受到原著作权保护.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈